A detailed history of Lpl Financial LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 114,322 shares of TGTX stock, worth $3.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,322
Previous 133,280 14.22%
Holding current value
$3.38 Million
Previous $2.37 Million 12.74%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$17.21 - $25.28 $326,267 - $479,258
-18,958 Reduced 14.22%
114,322 $2.67 Million
Q2 2024

Aug 07, 2024

BUY
$13.32 - $19.19 $250,122 - $360,349
18,778 Added 16.4%
133,280 $2.37 Million
Q1 2024

May 10, 2024

BUY
$13.02 - $21.3 $285,580 - $467,194
21,934 Added 23.7%
114,502 $1.74 Million
Q4 2023

Feb 14, 2024

BUY
$6.68 - $18.81 $7,882 - $22,195
1,180 Added 1.29%
92,568 $1.58 Million
Q3 2023

Nov 13, 2023

BUY
$8.36 - $26.5 $202,562 - $642,095
24,230 Added 36.08%
91,388 $764,000
Q2 2023

Jul 31, 2023

BUY
$15.48 - $35.0 $263,314 - $595,350
17,010 Added 33.92%
67,158 $1.67 Million
Q1 2023

May 10, 2023

BUY
$10.23 - $19.34 $115,527 - $218,406
11,293 Added 29.06%
50,148 $754,000
Q4 2022

Feb 07, 2023

BUY
$5.01 - $11.83 $57,514 - $135,808
11,480 Added 41.94%
38,855 $459,000
Q3 2022

Nov 14, 2022

SELL
$4.57 - $8.4 $5,781 - $10,626
-1,265 Reduced 4.42%
27,375 $162,000
Q2 2022

Aug 12, 2022

SELL
$3.74 - $10.66 $4,809 - $13,708
-1,286 Reduced 4.3%
28,640 $122,000
Q1 2022

May 16, 2022

BUY
$7.81 - $20.45 $20,555 - $53,824
2,632 Added 9.64%
29,926 $285,000
Q4 2021

Feb 14, 2022

BUY
$15.2 - $35.51 $7,007 - $16,370
461 Added 1.72%
27,294 $519,000
Q3 2021

Nov 15, 2021

BUY
$21.78 - $40.45 $162,827 - $302,404
7,476 Added 38.62%
26,833 $893,000
Q2 2021

Aug 13, 2021

BUY
$32.5 - $48.96 $257,042 - $387,224
7,909 Added 69.09%
19,357 $751,000
Q1 2021

May 14, 2021

SELL
$41.61 - $54.3 $371,826 - $485,224
-8,936 Reduced 43.84%
11,448 $552,000
Q4 2020

Feb 12, 2021

BUY
$25.27 - $54.9 $151,594 - $329,345
5,999 Added 41.7%
20,384 $1.06 Million
Q3 2020

Nov 09, 2020

BUY
$18.49 - $27.24 $1,497 - $2,206
81 Added 0.57%
14,385 $385,000
Q2 2020

Aug 13, 2020

BUY
$8.9 - $21.84 $8,766 - $21,512
985 Added 7.4%
14,304 $279,000
Q1 2020

May 14, 2020

SELL
$7.14 - $15.99 $4,833 - $10,825
-677 Reduced 4.84%
13,319 $131,000
Q4 2019

Feb 14, 2020

BUY
$5.1 - $11.2 $11,388 - $25,009
2,233 Added 18.98%
13,996 $155,000
Q3 2019

Nov 13, 2019

SELL
$5.38 - $8.99 $941 - $1,573
-175 Reduced 1.47%
11,763 $66,000
Q2 2019

Aug 09, 2019

BUY
$6.27 - $8.65 $1,937 - $2,672
309 Added 2.66%
11,938 $103,000
Q1 2019

May 08, 2019

SELL
$4.02 - $8.04 $1,137 - $2,275
-283 Reduced 2.38%
11,629 $93,000
Q4 2018

Feb 07, 2019

BUY
$3.44 - $5.76 $40,977 - $68,613
11,912 New
11,912 $49,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.